Sysmex America begins selling hemostasis instruments and reagents under the Sysmex brand in the United States

April 3, 2024
Agreement with Siemens Healthineers.

Sysmex America, Inc. announced its plan to sell hemostasis instruments and reagents to laboratories in the United States beginning in April, under the company’s mutual OEM agreement with Siemens Healthineers. 

With regulatory activities complete, the OEM agreement allows each company to distribute hemostasis instruments (provided by Sysmex) and reagents (provided by Siemens) under their respective brands. Both companies will market their hemostasis products and services independently of each other.

Sysmex leadership video announcement

To learn more about Sysmex hemostasis solutions, visit

Sysmex release

Courtesy of Cellares
Photo 12791064 © Chepko |
Photo 149835681 © Shutter2u |